RECENT NEWS

Life sciences firm Promega UK has announced the launch of a new programme of Continuing Professional Development (CPD) courses, designed to support those working in the clinical field of life sciences including biomedical scientists, pathologists, and life-sciences researchers.

IBMS President Joanna Andrew talks to Pathology in Practice at Congress 2025.

Pathology in Practice hears from Jennifer Dougan, National Sales Manager, Bruker and ELITech about the product offering from the two firms, which are exhibiting together at Congress for the first time.

Launch Diagnostics' Chris Waghorn tells Pathology in Practice about his company's presence at Congress this year.

Yannig Querel, Marketing Manager at Stago UK, tells Pathology in Practice about the new Stago sthem0 coagulation analysers, which are on display at Congress.

Una Health's Commercial Director POCT, Naomi Chant tells Pathology in Practice about some of the new products the company is showing at Congress.

Matt Casey, Marketing & Sales Support Manager, Sarstedt tells Pathology in Practice Editor Andy Myall about the firm's stand at Congress 2025.

Pathology in Practice hears from Dan Plews, Senior Business Development Manager, about Source LDPath's presence at Congress.

Pathology in Practice Editor Andy Myall hears what's new at Congress from Pro-Lab Diagnostics, with General Manager and Founder Mark Reed.

Pathology in Practice hears from David Wells, IBMS Chief Executive at Congress 2025.

Twenty-seven species of bacteria and fungi among the hundreds that live in people’s mouths have been collectively tied to a 3.5 times greater risk of developing pancreatic cancer, a study led by NYU Langone Health and its Perlmutter Cancer Center shows.

A single joint executive team is to be established at the Department of Health and Social Care (DHSC) and NHS England as part of the transition to one organisation.

The Institute of Biomedical Science (IBMS) has announced that it has commissioned Lord Patrick Carter to lead an independent UK-wide review of pathology services to benchmark today’s services and workforce to guide tomorrow’s decisions.

The Centre for Process Innovation (CPI) has published three interconnected reports offering the most comprehensive analysis to date of the challenges facing UK MedTech innovators.

A new partnership between OGT, a global leader in genomic research and diagnostic solutions, and QIAGEN Digital Insights (QDI), a leading provider of genomic interpretation and analysis tools, expands OGT’s bioinformatics capabilities by integrating QIAGEN’s advanced tertiary analysis solution, QCI Interpret, with its SureSeq NGS panels.

Proscia, a pathology AI company, has announced the next step in its collaboration with Amazon Web Services (AWS) to address two of digital pathology’s most pressing challenges: managing surging data volumes and standardising siloed data.

The September issue of PIP has now been published and is available to read online.

A team of immunologists at the University of Massachusetts Amherst has discovered a pre-wired ability in ‘resting’ T cells to remember past viral foes, a promising breakthrough for targeted cancer therapies.

Genomics England has announced the appointment of Dr Natalie Banner as its Chief Ethics and Engagement Officer.

Scientists have developed a new test that can decode when a cancer tumour first started growing and how fast it is growing, potentially allowing doctors to accurately predict when a patient will need treatment.